Abstracts

HIV INTEGRASE GENOTYPIC TESTING AND RESISTANCE IN THE UNITED STATES—9 JURISDICTIONS

In 2016, national drug resistance testing guidelines were updated to recommend providers include integrase (IN) genotypic testing at entry into HIV care if transmitted resistance to integrase strand transfer inhibitors (INSTI) is a concern. We used National HIV Surveillance System (NHSS) data to assess the prevalence of IN genotypic testing and INSTI-associated resistance. We analyzed…

PRE-ART TUBERCULOSIS AND TB-IRIS AFFECT THE HIV-1 RESERVOIR

Tuberculosis (TB) is the most common presenting illness of people living with HIV worldwide. TB-associated immune reconstitution inflammatory syndrome (IRIS) is an aberrant inflammatory response of TB in patients starting antiretroviral therapy (ART), especially with severe CD4 lymphopenia or disseminated TB. Previous studies show TB-IRIS is driven by rapid expansion of activated TB-specific CD4+ T-cells.…

CLONAL EXPANSION OF GENOME-INTACT HIV-1 IN FUNCTIONALLY POLARIZED T-CELL SUBSETS

HIV-1 remains an incurable disease due to long-lasting reservoirs of infected cells that are unaffected by suppressive antiretroviral therapy. However, the mechanisms that maintain long-term stability of such viral reservoirs are not well understood. Here, we used a near-full-genome deep sequencing approach to characterize HIV-1 DNA content in highly purified CD4 T cell subsets with…